Here’s the translation into American English:
—
Chronic inflammation has become one of the leading public health concerns worldwide, accounting for an alarming 50% of deaths. This phenomenon, known as a silent epidemic, is associated with multiple diseases that are often asymptomatic until advanced stages. Cardiovascular diseases, strokes, cancer, diabetes, and neurodegenerative diseases are just a few of the conditions directly linked to this type of inflammation.
In this context, resolvins—a group of molecules derived from fatty acids—have emerged as a promising therapeutic approach. According to a review conducted by Longevitas Labs, these lipid substances have shown the ability to reduce inflammation and contribute to increased longevity. Dr. Ángel Durántez, an expert in preventive medicine and the technical director of the company, points out that chronic inflammation is closely related to aging. “Poor dietary and lifestyle habits are directly associated with inflammatory processes, but there are ways to counteract this effect,” he states.
Research published in the journal “Nature” emphasizes that a high percentage of deaths worldwide are attributed to inflammatory diseases. Additionally, another study in the field of aging biology suggests that chronic inflammation could be an underlying factor in numerous age-related conditions. Dr. Durántez adds that from the age of 30-35, the body requires additional support due to aging, which makes supplementation an important consideration. This is especially relevant in situations of high physical and mental demand, where nutrients obtained from daily food may not be sufficient.
Researchers from Harvard University, led by Dr. Charles Serhan, have observed that natural production of resolvins decreases with age, which contributes to increased inflammation. However, thanks to technological advancements, precursors that can aid in their production have been identified, particularly from fish oil.
In light of this, Longevitas Labs has developed P-resolvins, a dietary supplement that uses advanced technology to extract and concentrate resolvin precursors. This product, which offers the highest concentration available on the market, is designed with various medical specialties in mind, including sports medicine, physiotherapy, rheumatology, dentistry, and aesthetic medicine. Ilona Calparsoro, CEO of Longevitas Labs, asserts that “P-resolvins boosts the natural production of resolvins and improves the management of chronic inflammation in different pathologies.”
The use of supplements like P-resolvins aims not only to treat existing inflammation but also serves as a preventive option to enhance health and overall well-being for an increasingly aware population regarding the importance of managing inflammation.
—
Let me know if you need any further assistance!
Referrer: MiMub in Spanish